Australia Microfluidics Market Size & Outlook, 2023-2030
Australia microfluidics market, 2018-2030 (US$M)
Related Markets
Australia microfluidics market highlights
- The Australia microfluidics market generated a revenue of USD 476.2 million in 2023 and is expected to reach USD 1,284.1 million by 2030.
- The Australia market is expected to grow at a CAGR of 15.2% from 2024 to 2030.
- In terms of segment, medical was the largest revenue generating technology in 2023.
- Medical is the most lucrative technology segment registering the fastest growth during the forecast period.
Microfluidics market data book summary
| Market revenue in 2023 | USD 476.2 million |
| Market revenue in 2030 | USD 1,284.1 million |
| Growth rate | 15.2% (CAGR from 2023 to 2030) |
| Largest segment | Medical |
| Fastest growing segment | Medical |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Medical, Non-Medical |
| Key market players worldwide | Illumina Inc, Roche Holding AG ADR, PerkinElmer, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Abbott Laboratories, Thermo Fisher Scientific Inc, Standard BioTools Inc |
Other key industry trends
- In terms of revenue, Australia accounted for 1.5% of the global microfluidics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan microfluidics market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 4,436.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Microfluidics Market Scope
Microfluidics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia microfluidics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microfluidics market will help companies and investors design strategic landscapes.
Medical was the largest segment with a revenue share of 84.15% in 2023. Horizon Databook has segmented the Australia microfluidics market based on medical, non-medical covering the revenue growth of each sub-segment from 2018 to 2030.
Over the past decade, the Australian microfluidics space has witnessed a paradigm shift in the applications and capabilities with regard to microfluidics technology. This is a rapidly growing field in Australia.
This can be attributed to the increasing adoption of microfluidic devices in clinics, increasing collaborative efforts between manufacturers, investors, and researchers, and expanding its applications in medical as well as nonmedical fields.
These companies implement various strategic initiatives to maintain their market position. SCHOTT MINIFAB collaborates with clients to offer contract manufacturing and product development services for diagnostics and life science microfluidics requirements.
Reasons to subscribe to Australia microfluidics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia microfluidics market databook
-
Our clientele includes a mix of microfluidics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia microfluidics market , including forecasts for subscribers. This country databook contains high-level insights into Australia microfluidics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia microfluidics market size, by technology, 2018-2030 (US$M)
Australia Microfluidics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
